Bristol-Myers Squibb (BMY)

48.24 +0.68 (1.43%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/25/19)
- M&A (9/30/19 *Est)

Latest Headlines

Bristol-Myers Squibb Co. (BMY) Estimate Raised At Cowen June 17, 2019 7:19 AM - StreetInsider Bristol-Myers Squibb Presents Updated Efficacy Data from Phase 2 Trial of Empliciti (elotuzumab) Plus Pomalidomide and Dexamethasone in Patients with Relapsed or Refractory Multiple Myeloma (RRMM) June 14, 2019 6:59 AM - BizWire Bristol-Myers Squibb Announces Dividend June 13, 2019 4:38 PM - BizWire New Mechanistic Study Explores the Relationship Between a Key Genetic Marker and Clinical Efficacy of ORENCIA® (abatacept) or adalimumab in Moderate-to-Severe Early Rheumatoid Arthritis Patients June 13, 2019 4:30 PM - BizWire Form 11-K BRISTOL MYERS SQUIBB CO For: Dec 31 June 13, 2019 11:59 AM - SEC Filing Form 11-K BRISTOL MYERS SQUIBB CO For: Dec 31 June 13, 2019 11:56 AM - SEC Filing Form 11-K BRISTOL MYERS SQUIBB CO For: Dec 31 June 13, 2019 11:52 AM - SEC Filing Bristol-Myers Squibb Co. (BMY) PT Lowered to $51 at UBS June 13, 2019 6:27 AM - StreetInsider Form 4 BRISTOL MYERS SQUIBB CO For: Jun 10 Filed by: Powell Ann June 12, 2019 4:40 PM - SEC Filing Bristol-Myers Squibb to Announce Results for Second Quarter 2019 on July 25, 2019 June 6, 2019 6:59 AM - BizWire Form 8-K BRISTOL MYERS SQUIBB CO For: Jun 05 June 5, 2019 8:25 AM - SEC Filing Bristol-Myers Squibb (BMY) Announces Leadership Team Upon Completion of Pending Merger with Celgene (CELG) June 5, 2019 7:02 AM - StreetInsider Bristol-Myers Squibb Announces Post-Closing Leadership Team June 5, 2019 6:59 AM - BizWire Bristol-Myers Squibb to Take Part in Goldman Sachs 40th Annual Global Healthcare Conference June 4, 2019 12:23 PM - BizWire Bristol-Myers Squibb (BMY) Announces Five-Year Survival Observed in Longest Follow-up to Date of Advanced Melanoma Patients Treated with Opdivo and Yervoy June 3, 2019 2:16 PM - StreetInsider Five-Year Survival Observed in Longest Follow-up to Date of Advanced Melanoma Patients Treated with the Combination of Opdivo (nivolumab) and Yervoy (ipilimumab) June 3, 2019 2:15 PM - BizWire Heat Biologics (HTBX) Reports Promising Interim Phase 2 Lung Cancer Data Investigating HS-110 in Combination with Nivolumab (Opdivo) June 3, 2019 7:16 AM - StreetInsider Bristol-Myers Squibb (BMY) Announces First Presentation of Results for Opdivo Plus Yervoy Combination in Advanced HCC at ASCO June 3, 2019 7:03 AM - StreetInsider Bristol-Myers Squibb Announces First Presentation of Results for Opdivo (nivolumab) Plus Yervoy (ipilimumab) Combination in Advanced Hepatocellular Carcinoma at ASCO 2019 June 3, 2019 6:59 AM - BizWire Form 8-K BRISTOL MYERS SQUIBB CO For: May 29 May 30, 2019 4:42 PM - SEC Filing Goldman Sachs Starts Bristol-Myers Squibb Co. (BMY) at Buy May 28, 2019 2:39 AM - StreetInsider Form 8-K BRISTOL MYERS SQUIBB CO For: May 24 May 24, 2019 8:07 AM - SEC Filing Bristol-Myers Squibb Company Announces Extension of the Expiration Date for Exchange Offers for Celgene Corporation Notes May 24, 2019 6:59 AM - BizWire Jerome Zeldis, M.D., Ph.D, Former Chief Medical Officer of Celgene, to Join BioSig Board of Directors - Corrected Version May 21, 2019 7:54 AM - StreetInsider Jerome Zeldis, M.D., Ph.D, Former Chief Medical Officer of Celgene, to Join BioSig Board of Directors - Corrected Version May 21, 2019 7:52 AM - Globe NewsWire Form 4 BRISTOL MYERS SQUIBB CO For: May 16 Filed by: Santiago Karen Murphy May 20, 2019 4:38 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: May 16 Filed by: Samuels Theodore R. II May 20, 2019 4:38 PM - SEC Filing Dr. Jerome Zeldis, M.D., Ph.D, Former Chief Medical Officer of Celgene, to Join BioSig Board of Directors May 20, 2019 7:54 AM - StreetInsider Dr. Jerome Zeldis, M.D., Ph.D, Former Chief Medical Officer of Celgene, to Join BioSig Board of Directors May 20, 2019 7:52 AM - Globe NewsWire Argus Downgrades Bristol-Myers Squibb Co. (BMY) to Hold May 20, 2019 7:27 AM - StreetInsider Form 8-K BRISTOL MYERS SQUIBB CO For: May 16 May 16, 2019 5:02 PM - SEC Filing Bristol-Myers Squibb to Present New Data on 20 Types of Cancer from Across its Oncology Portfolio at ASCO and EHA 2019 May 16, 2019 4:15 PM - BizWire Elliott Management Enters Carbonite (CARB), Symantec (SYMC), (more...) - 13F May 15, 2019 5:10 PM - StreetInsider Baupost's 13F shows new stakes in Bristol-Myers Squibb (BMY), Celgene (CELG), increase in eBay (EBAY), CBS (CBS) (more...) May 15, 2019 4:57 PM - StreetInsider Award-Winning Actor and Producer Sterling K. Brown Joins Bristol-Myers Squibb in Effort to Share Stories of What It’s Like to Live with Cancer Today May 14, 2019 7:15 AM - BizWire Bristol-Myers Squibb to Take Part in the UBS Global Healthcare Conference May 14, 2019 6:59 AM - BizWire Form SC 13G BRISTOL MYERS SQUIBB CO Filed by: WELLINGTON MANAGEMENT GROUP LLP May 10, 2019 10:44 AM - SEC Filing Kitov Receives Notice of Allowance for Additional U.S. Patent Covering its Commercial Product Consensi™ May 10, 2019 9:22 AM - StreetInsider Kitov Receives Notice of Allowance for Additional U.S. Patent Covering its Commercial Product Consensi™ May 10, 2019 9:20 AM - Globe NewsWire Kitov to Present Clinical Development Plan for Oncology Candidate NT-219 at the 18th MIXiii-BIOMED Conference May 9, 2019 8:32 AM - StreetInsider Kitov to Present Clinical Development Plan for Oncology Candidate NT-219 at the 18th MIXiii-BIOMED Conference May 9, 2019 8:30 AM - Globe NewsWire Bristol-Myers Squibb (BMY) Phase 3 CheckMate -498 Study Did Not Meet Primary Endpoint of OS with Opdivo Plus Radiation in Patients with Newly Diagnosed MGMT-Unmethylated GBM May 9, 2019 7:01 AM - StreetInsider Bristol-Myers Squibb Announces Phase 3 CheckMate -498 Study Did Not Meet Primary Endpoint of Overall Survival with Opdivo (nivolumab) Plus Radiation in Patients with Newly Diagnosed MGMT-Unmethylated May 9, 2019 6:59 AM - BizWire Form 8-K BRISTOL MYERS SQUIBB CO For: May 07 May 8, 2019 5:04 PM - SEC Filing IFM Therapeutics and Novartis Complete Previously Announced Acquisition of IFM Tre May 8, 2019 7:00 AM - PR NewsWire Bristol-Myers Squibb Company Prices $19 Billion of Senior Unsecured Notes May 8, 2019 6:59 AM - BizWire Bristol-Myers Squibb (BMY) to sell $19 billion of bonds to fund Celgene (CELG) deal - Bloomberg May 7, 2019 1:20 PM - StreetInsider Form 4 BRISTOL MYERS SQUIBB CO For: May 05 Filed by: Caforio Giovanni May 6, 2019 4:41 PM - SEC Filing Form 4/A BRISTOL MYERS SQUIBB CO For: Oct 02 Filed by: Biondi Paul May 6, 2019 4:41 PM - SEC Filing JPMorgan Reinstates Bristol-Myers Squibb Co. (BMY) at Overweight May 3, 2019 6:45 AM - StreetInsider Barclays Upgrades Bristol-Myers Squibb Co. (BMY) to Overweight May 3, 2019 4:40 AM - StreetInsider Kitov Pharma (KTOV) Announces Retirement of Founder and Executive Chairman Dr. Paul Waymack May 2, 2019 5:26 PM - StreetInsider Kitov Announces Retirement of Founder and Executive Chairman Dr. Paul Waymack May 2, 2019 4:45 PM - Globe NewsWire Kitov Announces Retirement of Founder and Executive Chairman Dr. Paul Waymack May 2, 2019 4:45 PM - StreetInsider Form 8-K BRISTOL MYERS SQUIBB CO For: May 01 May 2, 2019 6:04 AM - SEC Filing Bristol-Myers Squibb Company Announces Results of Early Participation in Exchange Offers and Consent Solicitations for Celgene Corporation Notes May 1, 2019 9:06 PM - BizWire Bristol-Myers Squibb Company Announces Launch of Private Offering of Senior Unsecured Notes May 1, 2019 5:46 PM - BizWire Form 8-K BRISTOL MYERS SQUIBB CO For: May 01 May 1, 2019 5:25 PM - SEC Filing Form 8-K BRISTOL MYERS SQUIBB CO For: May 01 May 1, 2019 8:31 AM - SEC Filing Form DEF 14A BRISTOL MYERS SQUIBB CO For: May 29 April 30, 2019 4:53 PM - SEC Filing Bristol-Myers Squibb Co. (BMY) PT Raised to $66 at BMO Capital April 26, 2019 7:46 AM - StreetInsider Form 10-Q BRISTOL MYERS SQUIBB CO For: Mar 31 April 25, 2019 11:40 AM - SEC Filing Form 8-K BRISTOL MYERS SQUIBB CO For: Apr 25 April 25, 2019 8:07 AM - SEC Filing Bristol-Myers profit slightly tops Wall Street view on blood thinner sales April 25, 2019 7:11 AM - StreetInsider Bristol-Myers Squibb (BMY) Tops Q1 EPS by 1c, Maintains EPS Guidance April 25, 2019 7:00 AM - StreetInsider Bristol-Myers Squibb Reports First Quarter Financial Results April 25, 2019 6:59 AM - BizWire Bristol-Myers Squibb (BMY) option implied volatility increases into EPS April 24, 2019 9:50 AM - StreetInsider Bristol-Myers Squibb (BMY) option implied volatility flat into EPS and outlook April 24, 2019 6:09 AM - StreetInsider Form 8-K BRISTOL MYERS SQUIBB CO For: Apr 17 April 17, 2019 8:35 AM - SEC Filing Bristol-Myers Squibb Company Announces Commencement of Exchange Offers and Consent Solicitations for Celgene Notes April 17, 2019 8:18 AM - BizWire Bristol-Myers Squibb Co. (BMY) PT Raised to $63 at BMO Capital April 17, 2019 6:46 AM - StreetInsider Form 8-K BRISTOL MYERS SQUIBB CO For: Apr 12 April 12, 2019 5:28 PM - SEC Filing Bristol-Myers Squibb Shareholders Approve Celgene Acquisition April 12, 2019 10:48 AM - BizWire Celgene (CELG) Stockholders Approve Acquisition by Bristol-Myers Squibb (BMY) April 12, 2019 10:34 AM - StreetInsider Celgene Stockholders Approve Proposed Acquisition by Bristol-Myers Squibb April 12, 2019 10:33 AM - BizWire Celgene (CELG) call put ratio 2.5 calls to 1 put into Bristol-Myers Squibb (BMY) Wins Shareholder Vote on Celgene Takeover April 12, 2019 10:25 AM - StreetInsider Bristol-Myers Squibb (BMY) Wins Shareholder Vote on Celgene (CELG) Takeover - Bloomberg April 12, 2019 10:23 AM - StreetInsider Bristol-Myers Squibb (BMY) is Said to be Poised to Win Celgene (CELG) Deal Vote - Bloomberg April 12, 2019 8:42 AM - StreetInsider Kitov Announces Key Milestone in FameWave Acquisition April 12, 2019 8:29 AM - StreetInsider Kitov Announces Key Milestone in FameWave Acquisition April 12, 2019 8:28 AM - Globe NewsWire FameWave Announces Clinical Collaboration with Bristol Myers Squibb for the Planned Phase 1/2 Trial in Non-Small Cell Lung Cancer to Evaluate Immuno-Oncology Candidate CM-24 in Combination with Nivolu April 12, 2019 7:50 AM - StreetInsider FameWave Announces Clinical Collaboration with Bristol Myers Squibb for the Planned Phase 1/2 Trial in Non-Small Cell Lung Cancer to Evaluate Immuno-Oncology Candidate CM-24 in Combination with Nivolu April 12, 2019 7:49 AM - Globe NewsWire Bristol-Myers Squibb Receives 2019 ENERGY STAR® Partner of the Year – Sustained Excellence Award April 11, 2019 6:59 AM - BizWire Form 4 BRISTOL MYERS SQUIBB CO For: Apr 03 Filed by: Lynch Thomas J. Jr. April 5, 2019 4:33 PM - SEC Filing Form 8-K BRISTOL MYERS SQUIBB CO For: Apr 04 April 4, 2019 4:25 PM - SEC Filing Bristol-Myers Squibb (BMY) option implied volatility flat on expectation for Celgene (CELG) April 3, 2019 11:07 AM - StreetInsider Form 4 BRISTOL MYERS SQUIBB CO For: Mar 31 Filed by: Vousden Karen H April 2, 2019 4:53 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Mar 31 Filed by: Samuels Theodore R. II April 2, 2019 4:52 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Mar 31 Filed by: Storch Gerald L April 2, 2019 4:52 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Mar 31 Filed by: Paliwal Dinesh C April 2, 2019 4:51 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Mar 31 Filed by: LACY ALAN J April 2, 2019 4:50 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Mar 31 Filed by: GROBSTEIN MICHAEL April 2, 2019 4:50 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Mar 31 Filed by: Emmens Matthew April 2, 2019 4:49 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Mar 31 Filed by: BERTOLINI ROBERT J April 2, 2019 4:48 PM - SEC Filing Form 4 BRISTOL MYERS SQUIBB CO For: Mar 31 Filed by: Arduini Peter J April 2, 2019 4:47 PM - SEC Filing Bristol-Myers Squibb (BMY) Announces Long-Term Survival Results from Opdivo in Lung Cancer April 2, 2019 1:03 PM - StreetInsider Bristol-Myers Squibb Announces Long-Term Survival Results from Pooled Analyses of Opdivo (nivolumab) in Previously-Treated Non-Small Cell Lung Cancer Patients April 2, 2019 1:00 PM - BizWire Bristol-Myers Squibb (BMY) option implied volatility flat April 1, 2019 4:54 AM - StreetInsider Novartis to Acquire IFM Tre to Develop First-In-Class NLRP3 Antagonist Portfolio Targeting Innate Immune System April 1, 2019 1:15 AM - PR NewsWire Form DFAN14A BRISTOL MYERS SQUIBB CO Filed by: Starboard Value LP March 29, 2019 4:00 PM - SEC Filing Bristol-Myers Squibb Issues Statement on Celgene’s Settlement with Alvogen on Revlimid® Patent Litigation March 29, 2019 1:33 PM - BizWire Starboard to withdraw its proxy solicitation to vote against the Celgene (CELG)/Bristol-Myers (BMY) deal March 29, 2019 12:03 PM - StreetInsider Starboard Issues Statement on Bristol-Myers March 29, 2019 12:02 PM - PR NewsWire Bristol-Myers Squibb (BMY) puts active after ISS recommends in favor of Celgene (CELG) deal March 29, 2019 11:38 AM - StreetInsider Active options: TSLA BB BMY FB COTY BABA NFLX JD WFC March 29, 2019 11:27 AM - StreetInsider Bristol-Myers Squibb (BMY) Confirms ISS and Glass Lewis Recommend Shareholders Vote for Proposed Merger with Celgene (CELG) March 29, 2019 11:14 AM - StreetInsider Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Bristol-Myers Squibb Shareholders Vote “FOR” Proposed Merger with Celgene March 29, 2019 11:13 AM - BizWire Celgene (CELG)/Bristol-Myers Squibb (BMY) Deal Spread Collapses to 4.1% March 29, 2019 10:19 AM - StreetInsider Glass Lewis Recommends Bristol-Myers Squibb (BMY) Holders Vote for Celgene (CELG) Deal - Bloomberg March 29, 2019 9:51 AM - StreetInsider Bristol-Myers Squibb (BMY) option implied volatility flat into ISS recommends in favor of Celgene (CELG) deal March 29, 2019 9:30 AM - StreetInsider Pre-Open Stock Movers 03/29: (BOXL) (PRGS) (CELG) Higher; (SGH) (RH) (CHMA) Lower (more...) March 29, 2019 9:27 AM - StreetInsider ISS Recommends Shareholders Vote 'FOR' Bristol-Myers Squibb (BMY)/Celgene (CELG) Deal March 29, 2019 9:17 AM - StreetInsider ISS Recommends Bristol-Myers Squibb (BMY) Holders Vote for Celgene (CELG) Deal - CNBC March 29, 2019 9:10 AM - StreetInsider Celgene (CELG) Shares Spike 6% March 29, 2019 9:02 AM - StreetInsider Active options: LULU AMZN GE PBR DB MU BMY BA MSFT T NFLX NLSN March 29, 2019 4:41 AM - StreetInsider Form DFAN14A BRISTOL MYERS SQUIBB CO Filed by: Starboard Value LP March 28, 2019 5:01 PM - SEC Filing Celgene (CELG) Drifts to Low, Down 2.5% March 28, 2019 3:04 PM - StreetInsider Starboard Mails Letter to All Bristol-Myers Squibb Shareholders March 28, 2019 10:07 AM - PR NewsWire IFM Therapeutics Announces Dosing of First Subjects in Phase 1 Healthy Volunteer Study of Lead NLRP3 Antagonist, IFM-2427 March 28, 2019 7:00 AM - PR NewsWire Bristol-Myers Squibb Co. (BMY) PT Raised to $68 at Societe Generale March 27, 2019 1:23 PM - StreetInsider Bristol-Myers Squibb (BMY) April calls active into ISS expected to weigh in on Celgene deal soon March 27, 2019 10:31 AM - StreetInsider Celgene (CELG) April puts active into ISS expected to weigh in on the Bristol-Myers Squibb (BMY)/Celgene (CELG) deal March 27, 2019 10:27 AM - StreetInsider ISS Seen Weighing in on Celgene (CELG)/Bristol-Myers Squibb (BMY) Deal on Monday - Faber March 27, 2019 10:08 AM - StreetInsider Bristol-Myers Squibb (BMY) Receives FTC Second Request in Connection with Celgene (CELG) Deal March 26, 2019 7:10 AM - StreetInsider Form 8-K BRISTOL MYERS SQUIBB CO For: Mar 25 March 26, 2019 7:05 AM - SEC Filing Bristol-Myers Squibb (BMY) Board Provides Open Letter Shareholder Regarding Merger Agreement with Celgene Corp. (CELG) March 25, 2019 7:02 AM - StreetInsider Bristol-Myers Squibb Board of Directors Sends Letter to Shareholders Highlighting the Compelling Strategic and Financial Rationale of the Celgene Transaction; Company Provides Additional Investor Mate March 25, 2019 6:59 AM - BizWire Form DFAN14A BRISTOL MYERS SQUIBB CO Filed by: Starboard Value LP March 22, 2019 5:22 PM - SEC Filing Starboard's Smith Says He is not Short Celgene (CELG) - CNBC March 22, 2019 10:32 AM - StreetInsider Bristol-Myers Squibb (BMY) Deal for Celgene (CELG) Will Likely Go Through - Barclays March 22, 2019 9:33 AM - StreetInsider Bristol-Myers Squibb (BMY) PT Raised At BMO On Combination With Celgene March 20, 2019 6:51 AM - StreetInsider Form DFAN14A BRISTOL MYERS SQUIBB CO Filed by: Starboard Value LP March 19, 2019 4:58 PM - SEC Filing No Smoking Gun from Starboard on Bristol-Myers (BMY)/Celgene (CELG) Deal; Sees ISS in Favor - Jefferies March 19, 2019 11:45 AM - StreetInsider Starboard Issues Investor Presentation Opposing Bristol-Myers Squibb's (BMY) Ill-Advised Proposed Acquisition of Celgene (CELG) March 19, 2019 7:04 AM - StreetInsider Starboard Issues Investor Presentation Opposing Bristol-Myers Squibb's Ill-Advised Proposed Acquisition of Celgene March 19, 2019 7:00 AM - PR NewsWire Bristol-Myers Squibb (BMY) Highlights Significant Benefits of Pending Transaction with Celgene (CELG) March 19, 2019 7:00 AM - StreetInsider Bristol-Myers Squibb Files Investor Presentation Highlighting Significant Benefits of Pending Transaction with Celgene March 19, 2019 6:59 AM - BizWire Full Article List